Alira Health

MEET2WIN 2025

May 6-7, 2025 | Bordeaux, France

We are pleased to share that we will attend MEET2WIN 2025, a unique European partnering event entirely dedicated to open innovation in oncology.

Our multidisciplinary team can guide you through every stage of your product lifecycle, from clinical development and real-world evidence to transaction advisory. Take this opportunity to connect with our delegates and discover how we can help you accelerate innovation and deliver tomorrow’s standard of care for oncology patients.

Want to meet at MEET2WIN 2025?

Meet Our Delegates

Benjamin Chambon
Esmaa Oulhissane

Esmaa Oulhissane
Business Development Manager,
RCD & PCT

Discover Our Oncology Expert Insights

White paper

Nuclear medicine is entering a game-changing era. Breakthroughs in radiopharmaceuticals, cutting-edge clinical advancements, and surging investments are propelling the field forward.

Download now

Case study

Our pharma clients sought support to evaluate and leverage the data generated from US trial in other markets and develop a mitigation plan for gaps in evidence.

Learn more

Article

This article provides information about radiopharmaceuticals in nuclear medicine and in-house vs. Commercial production in key European markets.

Learn more

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.